1. European Pharmacopoeia, 9th ed. Strasbourg: Council of Europe, 2016;
2. Memorandum of Understanding for the implementation of the COST Action "European Network of Vaccine Adjuvants" (ENOVA) CA16231. COST Association AISBL, 23.06.2017;
3. Allen LVJ, Ansel HC. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2014;
4. Committee for medicinal products for human use (CHMP). Guideline on adjuvants in vaccines for human use, EMEA/CHMP/VEG/134716/2004, 2004;
5. Pati R, Shevtsov M, Sonawane A. Nanoparticle Vaccines Against Infectious Diseases. Front Immunol. 2018;9:2224;